elranatamab will increase the amount or effect of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Elranatamab causes cytokine launch syndrome (CRS) which will suppress activity of CYP enzymes, leading to enhanced exposure of CYP substrates.Duragesic® is useful for agony intense adequate to